vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $196.0M, roughly 1.2× Axsome Therapeutics, Inc.). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs -14.6%, a 19.6% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 11.5%). ONESPAWORLD HOLDINGS Ltd produced more free cash flow last quarter ($14.9M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 7.1%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AXSM vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $242.1M |
| Net Profit | $-28.6M | $12.1M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 6.8% |
| Net Margin | -14.6% | 5.0% |
| Revenue YoY | 65.0% | 11.5% |
| Net Profit YoY | 61.9% | -16.2% |
| EPS (diluted) | $-0.55 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $242.1M | ||
| Q3 25 | $171.0M | $258.5M | ||
| Q2 25 | $150.0M | $240.7M | ||
| Q1 25 | $121.5M | $219.6M | ||
| Q4 24 | $118.8M | $217.2M | ||
| Q3 24 | $104.8M | $241.7M | ||
| Q2 24 | $87.2M | $224.9M | ||
| Q1 24 | $75.0M | $211.2M |
| Q4 25 | $-28.6M | $12.1M | ||
| Q3 25 | $-47.2M | $24.3M | ||
| Q2 25 | $-48.0M | $19.9M | ||
| Q1 25 | $-59.4M | $15.3M | ||
| Q4 24 | $-74.9M | $14.4M | ||
| Q3 24 | $-64.6M | $21.6M | ||
| Q2 24 | $-79.3M | $15.8M | ||
| Q1 24 | $-68.4M | $21.2M |
| Q4 25 | -13.8% | 6.8% | ||
| Q3 25 | -27.0% | 10.2% | ||
| Q2 25 | -24.5% | 9.2% | ||
| Q1 25 | -46.9% | 7.7% | ||
| Q4 24 | -61.1% | 7.9% | ||
| Q3 24 | -59.8% | 10.3% | ||
| Q2 24 | -89.5% | 8.4% | ||
| Q1 24 | -89.7% | 8.0% |
| Q4 25 | -14.6% | 5.0% | ||
| Q3 25 | -27.6% | 9.4% | ||
| Q2 25 | -32.0% | 8.3% | ||
| Q1 25 | -48.9% | 7.0% | ||
| Q4 24 | -63.1% | 6.6% | ||
| Q3 24 | -61.7% | 8.9% | ||
| Q2 24 | -91.0% | 7.0% | ||
| Q1 24 | -91.1% | 10.0% |
| Q4 25 | $-0.55 | $0.12 | ||
| Q3 25 | $-0.94 | $0.23 | ||
| Q2 25 | $-0.97 | $0.19 | ||
| Q1 25 | $-1.22 | $0.15 | ||
| Q4 24 | $-1.54 | $0.13 | ||
| Q3 24 | $-1.34 | $0.20 | ||
| Q2 24 | $-1.67 | $0.15 | ||
| Q1 24 | $-1.44 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $16.3M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $88.3M | $542.6M |
| Total Assets | $689.8M | $707.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $16.3M | ||
| Q3 25 | $325.3M | $29.6M | ||
| Q2 25 | $303.0M | $35.0M | ||
| Q1 25 | $300.9M | $22.6M | ||
| Q4 24 | $315.4M | $57.4M | ||
| Q3 24 | $327.3M | $48.8M | ||
| Q2 24 | $315.7M | $62.5M | ||
| Q1 24 | $331.4M | $65.4M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $138.6M |
| Q4 25 | $88.3M | $542.6M | ||
| Q3 25 | $73.7M | $552.8M | ||
| Q2 25 | $73.1M | $548.3M | ||
| Q1 25 | $53.2M | $530.6M | ||
| Q4 24 | $57.0M | $554.5M | ||
| Q3 24 | $92.9M | $540.1M | ||
| Q2 24 | $102.9M | $532.7M | ||
| Q1 24 | $144.0M | $515.5M |
| Q4 25 | $689.8M | $707.1M | ||
| Q3 25 | $669.3M | $732.6M | ||
| Q2 25 | $639.8M | $731.8M | ||
| Q1 25 | $596.7M | $708.7M | ||
| Q4 24 | $568.5M | $746.4M | ||
| Q3 24 | $561.5M | $734.0M | ||
| Q2 24 | $548.2M | $756.8M | ||
| Q1 24 | $545.7M | $763.6M |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $20.0M |
| Free Cash FlowOCF − Capex | $-18.7M | $14.9M |
| FCF MarginFCF / Revenue | -9.6% | 6.2% |
| Capex IntensityCapex / Revenue | 0.0% | 2.1% |
| Cash ConversionOCF / Net Profit | — | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $20.0M | ||
| Q3 25 | $1.0M | $33.2M | ||
| Q2 25 | $-32.4M | $20.3M | ||
| Q1 25 | $-43.4M | $10.1M | ||
| Q4 24 | $-26.2M | $16.6M | ||
| Q3 24 | $-18.6M | $28.6M | ||
| Q2 24 | $-30.1M | $18.7M | ||
| Q1 24 | $-53.5M | $15.0M |
| Q4 25 | $-18.7M | $14.9M | ||
| Q3 25 | $988.0K | $27.6M | ||
| Q2 25 | $-32.4M | $17.6M | ||
| Q1 25 | $-43.7M | $8.4M | ||
| Q4 24 | $-26.2M | $13.2M | ||
| Q3 24 | $-18.7M | $27.5M | ||
| Q2 24 | $-30.2M | $17.6M | ||
| Q1 24 | $-53.6M | $13.7M |
| Q4 25 | -9.6% | 6.2% | ||
| Q3 25 | 0.6% | 10.7% | ||
| Q2 25 | -21.6% | 7.3% | ||
| Q1 25 | -36.0% | 3.8% | ||
| Q4 24 | -22.1% | 6.1% | ||
| Q3 24 | -17.9% | 11.4% | ||
| Q2 24 | -34.6% | 7.8% | ||
| Q1 24 | -71.4% | 6.5% |
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | 2.2% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.3% | 0.8% | ||
| Q4 24 | 0.0% | 1.5% | ||
| Q3 24 | 0.1% | 0.5% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 0.6% |
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
